Oral anticoagulant therapy and outcomes in new-onset atrial fibrillation during acute myocardial infarction: A systematic review and meta-analysis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Cardiol. Feb 26, 2026; 18(2): 114265
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.114265

Full Size Figure Download Figure

Figure 2 Risk of bias assessment in prognostic studies using the Quality in Prognosis Studies tool.

Citation: Pereverzeva KG, Glenza A, Yakushin SS. Oral anticoagulant therapy and outcomes in new-onset atrial fibrillation during acute myocardial infarction: A systematic review and meta-analysis. World J Cardiol 2026; 18(2): 114265
URL: https://www.wjgnet.com/1949-8462/full/v18/i2/114265.htm
DOI: https://dx.doi.org/10.4330/wjc.v18.i2.114265

Pereverzeva KG, Glenza A, Yakushin SS. Oral anticoagulant therapy and outcomes in new-onset atrial fibrillation during acute myocardial infarction: A systematic review and meta-analysis. World J Cardiol 2026; 18(2): 114265 [PMID: 41694039 DOI: 10.4330/wjc.v18.i2.114265]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.